155 related articles for article (PubMed ID: 23084389)
1. Toxic epidermal necrolysis in a 15-month-old girl successfully treated with amniotic membrane transplantation.
Barua A; McKee HD; Barbara R; Carley F; Biswas S
J AAPOS; 2012 Oct; 16(5):478-80. PubMed ID: 23084389
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases.
Gregory DG
Ophthalmology; 2011 May; 118(5):908-14. PubMed ID: 21440941
[TBL] [Abstract][Full Text] [Related]
3. Amniotic membrane grafting for conjunctival and lid surface disease in the acute phase of toxic epidermal necrolysis.
Tandon A; Cackett P; Mulvihill A; Fleck B
J AAPOS; 2007 Dec; 11(6):612-3. PubMed ID: 17681814
[TBL] [Abstract][Full Text] [Related]
4. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis.
John T; Foulks GN; John ME; Cheng K; Hu D
Ophthalmology; 2002 Feb; 109(2):351-60. PubMed ID: 11825823
[TBL] [Abstract][Full Text] [Related]
5. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
[TBL] [Abstract][Full Text] [Related]
6. Sutureless Amniotic Membrane Transplantation in a Pediatric Patient with Acute Toxic Epidermal Necrolysis.
Baş Z; Uçakhan Gündüz Ö
Turk J Ophthalmol; 2019 Dec; 49(6):356-360. PubMed ID: 31893592
[TBL] [Abstract][Full Text] [Related]
7. Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement.
Kobayashi A; Yoshita T; Sugiyama K; Miyashita K; Niida Y; Koizumi S; Tseng SC
Ophthalmology; 2006 Jan; 113(1):126-32. PubMed ID: 16324747
[TBL] [Abstract][Full Text] [Related]
8. Amniotic membrane transplantation in acute toxic epidermal necrolysis: histopathologic changes and ocular surface features after 1-year follow-up.
López-García JS; Rivas L; García-Lozano I; Conesa E; Elosua I; Murube J
Eur J Ophthalmol; 2014; 24(5):667-75. PubMed ID: 24519514
[TBL] [Abstract][Full Text] [Related]
9. Amniotic membrane therapy in the acute phase of toxic epidermal necrolysis.
Foulks GN
J AAPOS; 2007 Dec; 11(6):531. PubMed ID: 18086431
[No Abstract] [Full Text] [Related]
10. Amniotic Membrane-Covered Conformer and Fibrin Glue for Toxic Epidermal Necrolysis.
Chan S; Gole GA; Lee GA
Cornea; 2021 Apr; 40(4):525-528. PubMed ID: 33881813
[TBL] [Abstract][Full Text] [Related]
11. Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Shay E; Kheirkhah A; Liang L; Sheha H; Gregory DG; Tseng SC
Surv Ophthalmol; 2009; 54(6):686-96. PubMed ID: 19699503
[TBL] [Abstract][Full Text] [Related]
12. Successful Treatment of Acute Ocular-Involving Toxic Epidermal Necrolysis Using Amniotic Membrane Suture Fixated to Custom Designed Symblepharon Rings.
Cheung CS; Ali A; Chew HF
Cornea; 2016 Apr; 35(4):578-81. PubMed ID: 26863497
[TBL] [Abstract][Full Text] [Related]
13. Sutureless Amniotic Membrane Transplantation Using Pediatric Nasogastric Tube for Patients With Acute Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Ceylan A; Mergen B; Aydin FO; Avci E; Yildirim Y
Eye Contact Lens; 2023 May; 49(5):199-203. PubMed ID: 36943174
[TBL] [Abstract][Full Text] [Related]
14. Amniotic membrane transplantation for Stevens-Johnson syndrome/toxic epidermal necrolysis: the Toronto experience.
Yang Y; Fung SSM; Chew H; Mireskandari K; Ali A
Br J Ophthalmol; 2021 Sep; 105(9):1238-1243. PubMed ID: 32830126
[No Abstract] [Full Text] [Related]
15. Successful treatment of acute ocular involvement in Stevens-Johnson syndrome with amniotic membrane transplantation: a case report.
Hess TM; Chew HF
Can J Ophthalmol; 2012 Dec; 47(6):e44-6. PubMed ID: 23217513
[No Abstract] [Full Text] [Related]
16. Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Shanbhag SS; Rashad R; Chodosh J; Saeed HN
Am J Ophthalmol; 2019 Dec; 208():331-341. PubMed ID: 31326519
[TBL] [Abstract][Full Text] [Related]
17. Amniotic membrane transplantation in ocular surface disorders.
Datta H; Sarkar K; Chatterjee PR
J Indian Med Assoc; 2004 Dec; 102(12):726-9. PubMed ID: 15871361
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and limitation of sutureless amniotic membrane transplantation for acute toxic epidermal necrolysis.
Shay E; Khadem JJ; Tseng SC
Cornea; 2010 Mar; 29(3):359-61. PubMed ID: 20098313
[TBL] [Abstract][Full Text] [Related]
19. Indications and outcomes of amniotic membrane transplantation in the management of acute stevens-johnson syndrome and toxic epidermal necrolysis: a case-control study.
Hsu M; Jayaram A; Verner R; Lin A; Bouchard C
Cornea; 2012 Dec; 31(12):1394-402. PubMed ID: 23135531
[TBL] [Abstract][Full Text] [Related]
20. Amniotic membrane with living related corneal limbal/conjunctival allograft for ocular surface reconstruction in Stevens-Johnson syndrome.
Gomes JA; Santos MS; Ventura AS; Donato WB; Cunha MC; Höfling-Lima AL
Arch Ophthalmol; 2003 Oct; 121(10):1369-74. PubMed ID: 14557171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
